This site is intended for health professionals only

Published on 11 July 2014

Share this story:
Twitter
LinkedIn

Childhood stomach bug cases drop by 69% since vaccine introduction

The number of confirmed cases of rotavirus has dropped by 69% since a vaccine to protect against the disease was introduced in the UK a year ago.

The number of confirmed cases of rotavirus has dropped by 69% since a vaccine to protect against the disease was introduced in the UK a year ago.

This is according to statistics published by Public Health England.(1)
Between July and June for the 10 years before the vaccine was introduced, an average of 14,127 lab-reported cases of rotavirus – a highly infectious and occasionally severe stomach bug that affects babies and young children(2) –  occurred in the UK each year. That figure fell to 4,490 between July 2013 and June 2014.(1) A two-dose, oral vaccine to protect against rotavirus was introduced on the NHS for babies at the age of two and three months in July 2013. The vast majority of babies tolerate the vaccine very well. A small number develop restlessness, irritability or mild diarrhoea.
Rotavirus causes an unpleasant bout of diarrhoea, sometimes with vomiting, tummy ache and fever. Before the vaccine was introduced, around 130,000 cases resulted in a GP visit in England and Wales each year and around 13,000 children ended up in hospital as a result of the bug(3) because of complications such as extreme dehydration. A very small number of children die from rotavirus infection each year.(2)
Dr Peter Basile, medical manager for vaccines at GSK, which manufactures the rotavirus vaccine, Rotarix, said: “These figures are fantastic news. The addition of our vaccine to the standard set of immunisations given from birth has been a huge success so far, preventing a horrible illness in many babies.
“A recent survey looking at uptake showed that around 88% of babies are being given both doses of the rotavirus vaccine in the UK.(4) While this is encouraging and a higher uptake than we’d expect for a new vaccine, there’s still more we can do to help make sure every baby stands the best chance of avoiding this virus.”

References

  1. PHE Monthly National Norovirus Report. Summary of surveillance of norovirus and rotavirus. 10 July 2014. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1287143931777. (Last accessed July 2014)
  2. NHS Choices. http://www.nhs.uk/Conditions/vaccinations/Pages/rotavirus-vaccine.aspx. (Last accessed June 2014).
  3. NHS Factsheet. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/193110/DoH_8415__RotaVirus_factsheet_8pp_04_accessible.pdf. (Last accessed June 2014).
  4. Public Health England news story. https://www.gov.uk/government/news/successful-start-to-rotavirus-vaccination-programme. (Last accessed June 2014).


Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn